Pharmaceutical company Rusan Pharma has launched a new active pharmaceutical ingredients (API) manufacturing plant at Pithampur, Madhya Pradesh. At the opening, at the invitation of the company, the commercial director of Dori-Darmon JSC Nurali Khasanov and the head of Fargona Dori-Darmon JSC Muhammadamin Tursunov took part.

The company is known for its innovative products in the treatment of drug addiction, Parkinson's disease, and products for the treatment of moderate to severe pain. They also produce nicotine transdermal patches for smoking cessation.

The new plant will create 300 jobs and have a production capacity of 400 metric tons of API per year.
The new facility will augment Rusan Pharma's existing API manufacturing capacity to supply critical APIs to meet the growing demand for its addiction treatment and pain management products in India and abroad.

The joint stock company "Dori-Darmon" has been cooperating with Rusan Pharma for more than 20 years. Over many years of cooperation, the company has established itself as a reliable supplier of vital drugs.

The team of AK "Dori-Darmon" congratulates Rusan Pharma on the opening of the new plant, wishes success and hopes that the cooperation of our companies will continue for many more decades!